Case Report: Infant With Congenital Adrenal Hyperplasia and 47,XXY

Authors

Sophia Q. Song, Department of Research, The Focus Foundation, Davidsonville, MD, United States.
Andrea Gropman, Division of Neurogenetics and Developmental Pediatrics, Children's National Health System, Washington, D.C., DC, United States.
Robert W. Benjamin, Pediatric Endocrinology, Duke Children's Hospital, Durham, NC, United States.
Francie Mitchell, Department of Research, The Focus Foundation, Davidsonville, MD, United States.
Michaela R. Brooks, Department of Research, The Focus Foundation, Davidsonville, MD, United States.
Mary P. Hamzik, Department of Research, The Focus Foundation, Davidsonville, MD, United States.
Kira Sampson, Department of Research, The Focus Foundation, Davidsonville, MD, United States.
Ritika Kommareddi, Department of Research, The Focus Foundation, Davidsonville, MD, United States.
Teresa Sadeghin, Department of Research, The Focus Foundation, Davidsonville, MD, United States.
Carole A. Samango-Sprouse, Department of Research, The Focus Foundation, Davidsonville, MD, United States.

Document Type

Journal Article

Publication Date

1-1-2021

Journal

Frontiers in genetics

Volume

12

DOI

10.3389/fgene.2021.808006

Keywords

XXY (aneuploidy of klinefelter syndrome); case report; congenital adrenal hyperplasia; klinefelter syndrome; neurodevelopment

Abstract

Congenital adrenal hyperplasia is a group of autosomal recessive disorders in which enzymes in the cortisol biosynthesis pathways are disrupted by gene mutations. The most common form of congenital adrenal hyperplasia, caused by 21-hydroxylase deficiency, is characterized by decreased cortisol and aldosterone synthesis and excessive androgen production. Adult height is often compromised in affected patients. Intellectual capability remains intact in patients with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency, based on previous studies. 47,XXY (KS) is a sex chromosomal aneuploidy that manifests with hypergonadotropic hypogonadism, tall stature, and variable intellectual and behavioral dysfunction. This clinical report describes an infant with 21-hydroxylase deficiency congenital adrenal hyperplasia and 47,XXY. The results of his neurodevelopmental, endocrine, neurological, and physical therapy evaluations during his first 22 months are included and were normal. This is the first published case investigating the neurodevelopmental profile of a patient with the combination of these two genetic disorders.

APA Citation

Song, Sophia Q.; Gropman, Andrea; Benjamin, Robert W.; Mitchell, Francie; Brooks, Michaela R.; Hamzik, Mary P.; Sampson, Kira; Kommareddi, Ritika; Sadeghin, Teresa; and Samango-Sprouse, Carole A., "Case Report: Infant With Congenital Adrenal Hyperplasia and 47,XXY" (2021). GW Authored Works. Paper 265.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/265

Department

Pediatrics